{"id":10961,"date":"2020-10-23T15:45:58","date_gmt":"2020-10-23T13:45:58","guid":{"rendered":"https:\/\/iabnetz.de\/?post_type=news&#038;p=10961"},"modified":"2025-11-14T20:48:19","modified_gmt":"2025-11-14T19:48:19","slug":"abstracts-of-scientific-papers-and-posters-presented-at-the-annual-meeting-of-the-association-of-academic-physiatrists-medical-student-category-award-winner-tuning-algorithms-for-control-interfaces-16","status":"publish","type":"page","link":"https:\/\/relaunch.iabnetz.com\/en\/publikationen\/konsensusartikel\/abstracts-of-scientific-papers-and-posters-presented-at-the-annual-meeting-of-the-association-of-academic-physiatrists-medical-student-category-award-winner-tuning-algorithms-for-control-interfaces-16\/","title":{"rendered":"Botulinum Toxin Therapy for Treatment of Spasticity in Multiple Sclerosis: Review and Recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders Task Force: Dressler D et al."},"content":{"rendered":"<p><\/p>\n<div class=\"ff219\">\n<div class=\"ff25\">\n<div class=\"ff8\">\n<div id=\"c854\" class=\"csc-default\">\n<p><strong>Dressler D<br \/>\n<\/strong>Movement Disorders Section, Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany<br \/>\ndressler.dirk@mh-hannover.de<\/p>\n<p><strong>Bhidayasiri R<\/strong>: Chulalongkorn Centre for Excellence on Parkinson\u2019s Disease and Related Disorders, King Chulalongkorn Memorial Hospital, Bangkok, Thailand<br \/>\n<strong>Boholega S<\/strong>: Department of Neurology, King Faisal Specialist Hospital, Riyadh, Kingdom of Saudi Arabia<br \/>\n<strong>Chahidi A<\/strong>: Moroccan Society of Neurophysiology, Kingdom of Morocco<br \/>\n<strong>Mo Chung T<\/strong>: Hospital Sao Joaquim Beneficencia Portuguesa, Sao Paulo, Brazil<br \/>\n<strong>Ebke M<\/strong>: Neurologie, Dr. Becker Rhein-Sieg-Klinik, Nuembrecht, Germany<br \/>\n<strong>Jacinto LJ<\/strong>: director de servi\u00e7o da empresa CMRA Localidade, <span class=\"locality\">Lisboa e Regi\u00e3o, Portugal<br \/>\n<strong>Kaji R<\/strong>: Department of Neurology, University of Tokushima, Tokushima, Japan<br \/>\n<strong>Kanovsky P<\/strong>:\u00a0Department of Neurology, Palacky University, Olomouc, Czech Republic<br \/>\n<strong>Ko\u00e7er S<\/strong>: Head of Rehabilitation Department at Hopital du Jura,\u00a0Schweiz<br \/>\n<strong>Micheli F<\/strong>:\u00a0Department of Neurology, Hospital de Cl\u0131nicas Jose de San Mart\u0131n, University of Buenos Aires, Buenos Aires, Argentina<br \/>\n<strong>Orlova O<\/strong>: Clinic \u2018Cecil Plus\u2019, Moscow, Russia<br \/>\n<strong>Paus S<\/strong>: Klinik und Poliklinik f\u00fcr Neurologie Universit\u00e4tsklinikum Bonn, Deutschland<br \/>\n<strong>Pirtosek Z<\/strong>: Department of Neurology, Ljubljana University Medical Centre, Slovenia<br \/>\n<\/span><strong>Relja M<\/strong>: Department of Neurology, University of Zagreb, Zagreb, Croatia<br \/>\n<strong>Rosales R<\/strong>: Department of Neurology, University of Santo Tomas, Manila, Philippines<br \/>\n<strong>Sag\u00e1stegui-Rodr\u00edguez JA<\/strong>: <span class=\"_Xbe\">Centro M\u00e9dico Ingl\u00e9s, Monterrey,\u00a0Mexiko<br \/>\n<\/span><strong>Sch\u00f6nle PW<\/strong>: Neurologie, MATERNUS-Klinik fuer Rehabilitation, Bad Oeynhausen, Germany<br \/>\n<strong>Shahidi GA<\/strong>: \u200eIRAN University of Medical Sciences (IUMS), Teheran, Iran<br \/>\n<strong>Timerbaeva S<\/strong>: Scientific Research Institute of Neurology, Moscow, Russia<br \/>\n<strong>Walter U<\/strong>: Klinik und Poliklink f\u00fcr Neurologie, Universitaet Rostock, Deutschland<br \/>\n<strong>Adib Saberi F<\/strong>: IAB\u2013Interdisciplinary Working Group for Movement Disorders, Hamburg, Germany<\/p>\n<p>J Neurol\u00a0DOI 10.1007\/s00415-016-8304-z, 2016.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p><a href=\"http:\/\/iabnetz.de\/wp-content\/uploads\/2016\/11\/BT-MS-IAB.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Please click here!<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Abstract Botulinum toxin (BT) therapy is an established treatment of spasticity due to stroke. For multiple sclerosis (MS) spasticity this is not the case. IAB-Interdisciplinary Working Group for Movement Disorders formed a task force to explore the use of BT therapy for treatment of MS spasticity. &#8230;.<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":30424,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-full-width.php","meta":{"_acf_changed":false,"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"class_list":["post-10961","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/10961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/comments?post=10961"}],"version-history":[{"count":1,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/10961\/revisions"}],"predecessor-version":[{"id":30532,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/10961\/revisions\/30532"}],"up":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/30424"}],"wp:attachment":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/media?parent=10961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}